Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

Clinical trial NCT01215864 · COMPLETED

Trial details

NCT number: NCT01215864
Sponsor: Traslational Cancer Drugs Pharma, SL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2011-01-01
Primary completion: 2014-02-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.